Anesthesiology, Pain Medicine · Dallas, TX
NPI
1700813946
Since 2006
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
5
Medicare group memberships
Hospitals
0
Hospital affiliations
17950 Preston Rd, Ste 120
Dallas, TX, 75252
Phone (972) 483-5714
Groups this clinician bills Medicare through
Medicare paid, 2024
$258K
3,704 services
Medicare patients, 2024
265
Average age 65
Drug cost, 2024
$544K
13,313 prescriptions
Company payments, 2025
$799
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Muhammad Zulqarnain was code 99213 (office e&m - established), 897 times for 190 patients. In total Muhammad Zulqarnain billed 3,704 services in 53 codes, and Medicare paid $258K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 897 | 190 | $63.66 | $57K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 744 | 70 | $0.75 | $557 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 546 | 47 | $0.09 | $49.42 |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 425 | 177 | $241.15 | $102K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 399 | 64 | $0.10 | $41.19 |
| 20610 Joint Injection | Office | 61 | 33 | $49.57 | $3,023 |
| 64483 Nerve Block Injection - Back | Office | 56 | 34 | $216.76 | $12K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 46 | 28 | $338.44 | $16K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 46 | 28 | $185.18 | $8,518 |
| 64484 Nerve Block Injection - Back | Office | 38 | 22 | $87.24 | $3,315 |
| 64493 Nerve Block Injection - Back | Office | 36 | 21 | $207.40 | $7,466 |
| 64494 Nerve Block Injection - Back | Office | 36 | 21 | $106.19 | $3,823 |
| 99204 Office E&M - New | Office | 24 | 24 | $123.28 | $2,959 |
| 99203 Office E&M - New | Office | 23 | 23 | $80.89 | $1,860 |
| 64483 Nerve Block Injection - Back | Facility | 18 | 12 | $109.14 | $1,964 |
By year: 2022 $216K for 3,538 services; 2023 $224K for 4,246 services; 2024 $258K for 3,704 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 425 | 177 | $241.15 | $102K |
Medicare prescription drug claims, 2024
In 2024, the drug Muhammad Zulqarnain prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 3,580 prescriptions and refills. In total Muhammad Zulqarnain wrote 13,313 Medicare prescriptions that cost $544K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,580 | 3,580 | 657 | $109K |
| Gabapentin Generic | 1,510 | 1,550 | 322 | $18K |
| Cyclobenzaprine Hcl Generic | 1,127 | 1,141 | 263 | $9,232 |
| Tizanidine Hcl Generic | 906 | 934 | 197 | $8,129 |
| Buprenorphine Hcl Generic | 843 | 845 | 131 | $27K |
| Pregabalin Generic | 731 | 740 | 162 | $20K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 419 | 419 | 68 | $14K |
| Naloxone Hcl Generic | 388 | 388 | 216 | $24K |
| Methocarbamol Generic | 299 | 311 | 59 | $4,866 |
| Tramadol Hcl Generic | 270 | 270 | 62 | $2,435 |
| Diclofenac Sodium Generic | 259 | 279 | 72 | $9,759 |
| Baclofen Generic | 245 | 259 | 47 | $3,235 |
| Celecoxib Generic | 240 | 242 | 43 | $9,343 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 223 | 223 | 57 | $4,577 |
| Morphine Sulfate Er Morphine Sulfate | 214 | 215 | 36 | $4,987 |
Brand drugs: 312 claims; generic drugs: 13,001 claims; opioid claims: 5,439.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Muhammad Zulqarnain $799 ($799 in general payments such as food, travel and fees) from 6 companies. The largest payer was Abbott Laboratories with $535.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.